Department of Cancer Imaging, Peter MacCallum Cancer Centre, Grattan St, Melbourne, VIC, 3000, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
Cancer Imaging. 2022 Jul 6;22(1):33. doi: 10.1186/s40644-022-00470-6.
The distinction between true disease progression and radiation necrosis after stereotactic radiosurgery to intracranial metastases is a common, but challenging, clinical scenario. Improvements in systemic therapies are increasing the importance of this distinction. A variety of imaging techniques have been investigated, but the value of any individual technique is limited.
Assessment should extend beyond simply the appearances of the lesion at a given timepoint, but also consider local anatomy and lesion evolution. Firstly, enlargement of a metastasis is affected by local anatomical boundaries, such as the dural reflections or cerebrospinal fluid spaces. In contrast, the radiation dose administered with stereotactic radiosurgery does not respect these anatomical boundaries and is largely concentric around the treated lesion. Therefore, new, non-contiguous enhancement across such a boundary can be confidently attributed to radiation necrosis. Secondly, the dynamic nature of radiation necrosis may result in a change in lesion shape, with different portions of the lesion simultaneously enlarging and regressing. Regression of part of a lesion indicates radiation necrosis, even if the overall lesion enlarges. This case series describes these two features and provides illustrative clinical examples in which these features allowed a confident diagnosis of radiation necrosis.
The distinction between true disease progression and radiation necrosis should extend beyond just the appearances of the lesion. More nuanced interpretation incorporating a relationship to anatomical boundaries and a change in shape can improve accurate diagnosis of radiation necrosis.
在颅内转移瘤立体定向放射外科治疗后,区分真正的疾病进展和放射性坏死是一种常见但具有挑战性的临床情况。系统治疗的改进增加了这种区分的重要性。已经研究了多种成像技术,但任何单一技术的价值都有限。
评估不应仅局限于在给定时间点病变的外观,还应考虑局部解剖结构和病变演变。首先,转移瘤的增大受到局部解剖边界的影响,例如硬脑膜反射或脑脊液空间。相比之下,立体定向放射外科中给予的放射剂量不遵守这些解剖边界,而是主要围绕治疗的病变呈同心圆分布。因此,可以有信心地将跨越此类边界的新的、不连续的增强归因于放射性坏死。其次,放射性坏死的动态性质可能导致病变形状发生变化,病变的不同部分同时增大和缩小。病变的一部分缩小表明放射性坏死,即使整个病变增大。本病例系列描述了这两个特征,并提供了说明性的临床实例,其中这些特征可以对放射性坏死做出明确诊断。
区分真正的疾病进展和放射性坏死不应仅局限于病变的外观。更细致的解释,包括与解剖边界的关系和形状的变化,可以提高放射性坏死的准确诊断。